Suppr超能文献

接受维生素A治疗的视网膜色素变性患者的ω-3摄入量与视力

ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A.

作者信息

Berson Eliot L, Rosner Bernard, Sandberg Michael A, Weigel-DiFranco Carol, Willett Walter C

出版信息

Arch Ophthalmol. 2012 Jun;130(6):707-11. doi: 10.1001/archophthalmol.2011.2580.

Abstract

OBJECTIVE

To evaluate whether a diet high in long chain ω-3 fatty acids can slow the rate of visual acuity loss among patients with retinitis pigmentosa receiving vitamin A palmitate.

METHODS

We calculated dietary intake from questionnaires completed annually by 357 adult patients from 3 randomized trials who were all receiving vitamin A, 15 000 IU/d, for 4 to 6 years. Rates of visual acuity decline were compared between those with high (≥0.20 g/d) vs low (<0.20 g/d) ω-3 intake. Analyses took age into account.

RESULTS

Mean rates of decline of acuity were slower among those with high ω-3 intake: Early Treatment Diabetic Retinopathy Study distance acuity: high intake=0.59 letter per year, low intake=1.00 letter per year,P=.001; Snellen retinal acuity: high intake=1.5% per year, low intake=2.8% per year, P=.03.

CONCLUSIONS

We conclude that mean annual rates of decline in distance and retinal visual acuities in adults with retinitis pigmentosa receiving vitamin A, 15 000 IU/d,are slower over 4 to 6 years among those consuming a diet rich in ω-3 fatty acids. To our knowledge, this is the first report that nutritional intake can modify the rate of decline of visual acuity in retinitis pigmentosa.

摘要

目的

评估富含长链ω-3脂肪酸的饮食是否能减缓接受棕榈酸视黄醇治疗的视网膜色素变性患者的视力丧失速度。

方法

我们通过3项随机试验中的357名成年患者每年填写的问卷计算饮食摄入量,这些患者均接受每日15000国际单位的维生素A治疗,为期4至6年。比较ω-3摄入量高(≥0.20克/天)与低(<0.20克/天)的患者的视力下降率。分析时考虑了年龄因素。

结果

ω-3摄入量高的患者的平均视力下降速度较慢:糖尿病视网膜病变早期治疗研究远距离视力:高摄入量=每年0.59行,低摄入量=每年1.00行,P=0.001;斯内伦视网膜视力:高摄入量=每年1.5%,低摄入量=每年2.8%,P=0.03。

结论

我们得出结论,在接受每日15000国际单位维生素A治疗的视网膜色素变性成年患者中,摄入富含ω-3脂肪酸饮食的患者在4至6年期间远距离和视网膜视力的平均年下降速度较慢。据我们所知,这是第一份关于营养摄入可改变视网膜色素变性患者视力下降速度的报告。

相似文献

1
ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A.
Arch Ophthalmol. 2012 Jun;130(6):707-11. doi: 10.1001/archophthalmol.2011.2580.
3
ω-3 Intake in patients with retinitis pigmentosa receiving vitamin A.
JAMA Ophthalmol. 2013 Feb;131(2):267-8. doi: 10.1001/jamaophthalmol.2013.590.
4
ω-3 Intake in patients with retinitis pigmentosa receiving vitamin A-Reply.
JAMA Ophthalmol. 2013 Feb;131(2):267-8. doi: 10.1001/jamaophthalmol.2013.1722.
5
Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A.
Arch Ophthalmol. 2010 Apr;128(4):403-11. doi: 10.1001/archophthalmol.2010.32.
6
Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment.
Arch Ophthalmol. 2004 Sep;122(9):1297-305. doi: 10.1001/archopht.122.9.1297.
7
Association of Vitamin A Supplementation With Disease Course in Children With Retinitis Pigmentosa.
JAMA Ophthalmol. 2018 May 1;136(5):490-495. doi: 10.1001/jamaophthalmol.2018.0590.
8
Vitamin A and fish oils for preventing the progression of retinitis pigmentosa.
Cochrane Database Syst Rev. 2020 Jun 18;6(6):CD008428. doi: 10.1002/14651858.CD008428.pub3.
9
Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1298-304. doi: 10.1167/iovs.06-0971.
10
A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.
Arch Ophthalmol. 1993 Jun;111(6):761-72. doi: 10.1001/archopht.1993.01090060049022.

引用本文的文献

2
Evaluating therapeutic potential of NR2E3 doses in the rd7 mouse model of retinal degeneration.
Sci Rep. 2024 Jul 17;14(1):16490. doi: 10.1038/s41598-024-67095-6.
5
Potential therapeutic strategies for photoreceptor degeneration: the path to restore vision.
J Transl Med. 2022 Dec 7;20(1):572. doi: 10.1186/s12967-022-03738-4.
6
Genetic, environmental and other risk factors for progression of retinitis pigmentosa.
Int J Ophthalmol. 2022 May 18;15(5):828-837. doi: 10.18240/ijo.2022.05.21. eCollection 2022.
7
Nonretinoid chaperones improve rhodopsin homeostasis in a mouse model of retinitis pigmentosa.
JCI Insight. 2022 May 23;7(10):e153717. doi: 10.1172/jci.insight.153717.
8
The Role of Vitamin A in Retinal Diseases.
Int J Mol Sci. 2022 Jan 18;23(3):1014. doi: 10.3390/ijms23031014.
9
Stem cell transplantation as a progressing treatment for retinitis pigmentosa.
Cell Tissue Res. 2022 Feb;387(2):177-205. doi: 10.1007/s00441-021-03551-3. Epub 2022 Jan 10.
10
Mitigating the pro-oxidant state and melanogenesis of Retinitis pigmentosa: by counteracting mitochondrial dysfunction.
Cell Mol Life Sci. 2021 Dec;78(23):7491-7503. doi: 10.1007/s00018-021-04007-1. Epub 2021 Oct 31.

本文引用的文献

1
Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A.
Arch Ophthalmol. 2010 Apr;128(4):403-11. doi: 10.1001/archophthalmol.2010.32.
2
Microscopic Observations in a Case of Retinitis Pigmentosa.
Trans Am Ophthalmol Soc. 1930;28:176-95.
3
Primary chorioretinal aberrations with night blindness; pathology.
Trans Am Acad Ophthalmol Otolaryngol. 1950 Jul-Aug;54:629-61.
5
Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment.
Arch Ophthalmol. 2004 Sep;122(9):1297-305. doi: 10.1001/archopht.122.9.1297.
6
A routine method of clinical electroretinography.
Acta Ophthalmol Suppl. 1962;Suppl 70:15-31. doi: 10.1111/j.1755-3768.1962.tb00304.x.
7
Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.
Ophthalmology. 1999 Feb;106(2):258-68. doi: 10.1016/S0161-6420(99)90064-7.
8
Rates of change differ among measures of visual function in patients with retinitis pigmentosa.
Ophthalmology. 1996 Mar;103(3):398-405. doi: 10.1016/s0161-6420(96)30679-9.
9
A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.
Arch Ophthalmol. 1993 Jun;111(6):761-72. doi: 10.1001/archopht.1993.01090060049022.
10
Retinitis pigmentosa. The Friedenwald Lecture.
Invest Ophthalmol Vis Sci. 1993 Apr;34(5):1659-76.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验